These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11269566)
1. Dichloroacetate: population pharmacokinetics with a pharmacodynamic sequential link model. Williams PJ; Lane JR; Turkel CC; Capparelli EV; Dziewanowska Z; Fox AW J Clin Pharmacol; 2001 Mar; 41(3):259-67. PubMed ID: 11269566 [TBL] [Abstract][Full Text] [Related]
2. Dichloroacetate for lactic acidosis in severe malaria: a pharmacokinetic and pharmacodynamic assessment. Krishna S; Supanaranond W; Pukrittayakamee S; Karter D; Supputamongkol Y; Davis TM; Holloway PA; White NJ Metabolism; 1994 Aug; 43(8):974-81. PubMed ID: 8052155 [TBL] [Abstract][Full Text] [Related]
3. Population kinetics, efficacy, and safety of dichloroacetate for lactic acidosis due to severe malaria in children. Agbenyega T; Planche T; Bedu-Addo G; Ansong D; Owusu-Ofori A; Bhattaram VA; Nagaraja NV; Shroads AL; Henderson GN; Hutson AD; Derendorf H; Krishna S; Stacpoole PW J Clin Pharmacol; 2003 Apr; 43(4):386-96. PubMed ID: 12723459 [TBL] [Abstract][Full Text] [Related]
4. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling. Fabre MA; Fuseau E; Ficheux H J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075 [TBL] [Abstract][Full Text] [Related]
5. Reduction of serum lactate by sodium dichloroacetate, and human pharmacokinetic-pharmacodynamic relationships. Fox AW; Sullivan BW; Buffini JD; Neichin ML; Nicora R; Hoehler FK; O'Rourke R; Stoltz RR J Pharmacol Exp Ther; 1996 Nov; 279(2):686-93. PubMed ID: 8930172 [TBL] [Abstract][Full Text] [Related]
6. Model Informed Dose Optimization of Dichloroacetate for the Treatment of Congenital Lactic Acidosis in Children. Mangal N; James MO; Stacpoole PW; Schmidt S J Clin Pharmacol; 2018 Feb; 58(2):212-220. PubMed ID: 28914978 [TBL] [Abstract][Full Text] [Related]
10. The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria. Krishna S; Supanaranond W; Pukrittayakamee S; Kuile FT; Ruprah M; White NJ Br J Clin Pharmacol; 1996 Jan; 41(1):29-34. PubMed ID: 8824690 [TBL] [Abstract][Full Text] [Related]
11. Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping Assay. Langaee T; Wagner R; Horne LP; Lawson LA; Becker C; Shahin M; Starostik P; Stacpoole PW Genet Test Mol Biomarkers; 2018 Apr; 22(4):266-269. PubMed ID: 29641284 [TBL] [Abstract][Full Text] [Related]
12. Dichloroacetate derivatives. Metabolic effects and pharmacodynamics in normal rats. Stacpoole PW; Gonzalez MG; Vlasak J; Oshiro Y; Bodor N Life Sci; 1987 Nov; 41(18):2167-76. PubMed ID: 3669916 [TBL] [Abstract][Full Text] [Related]
13. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270 [TBL] [Abstract][Full Text] [Related]
14. Amelioration of lactic acidosis with dichloroacetate during liver transplantation in humans. Shangraw RE; Winter R; Hromco J; Robinson ST; Gallaher EJ Anesthesiology; 1994 Nov; 81(5):1127-38. PubMed ID: 7978471 [TBL] [Abstract][Full Text] [Related]
15. Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats. Saghir SA; Schultz IR Environ Health Perspect; 2002 Aug; 110(8):757-63. PubMed ID: 12153755 [TBL] [Abstract][Full Text] [Related]
16. Age-related differences in the effect of dichloroacetate on postischemic lactate and acid clearance measured in vivo using magnetic resonance spectroscopy and microdialysis. Corbett R; Laptook A; Gee J; Garcia D; Silmon S; Tollefsbol G J Neurochem; 1998 Sep; 71(3):1205-14. PubMed ID: 9721746 [TBL] [Abstract][Full Text] [Related]
17. Effects of various doses of sodium dichloroacetate on hyperlactatemia in fed ischemic rats. Dimlich RV; Kaplan J; Timerding BL; Van Ligten PF Ann Emerg Med; 1989 Nov; 18(11):1162-71. PubMed ID: 2683899 [TBL] [Abstract][Full Text] [Related]
19. Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses. Curry SH; Lorenz A; Chu PI; Limacher M; Stacpoole PW Biopharm Drug Dispos; 1991 Jul; 12(5):375-90. PubMed ID: 1878534 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis. Xu H; Zhou W; Zhou D; Li J; Al-Huniti N J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]